Increased expression of matrix metalloproteinases-21 and -26 and TIMP-4 in pancreatic adenocarcinoma

This publication has 51 references indexed in Scilit:

• Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay
  Journal of Cell Science, 2007
• Matrix Metalloproteinase 26 Proteolysis of the NH2-Terminal Domain of the Estrogen Receptor β Correlates with the Survival of Breast Cancer Patients
  Cancer Research, 2006
• Molecular prognostic markers in pancreatic cancer: A systematic review
  Published by Elsevier ,2005
• Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma
  Carcinogenesis: Integrative Cancer Research, 2004
• RETRACTED: Glucose transporter-1 gene expression is associated with pancreatic cancer invasiveness and MMP-2 activity
  Surgery, 2004
• Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP‐3 is associated with adjuvant endocrine therapy success
  The Journal of Pathology, 2004
• Matrix Metalloproteinase-21 Is Expressed Epithelially During Development and in Cancer and Is Up-Regulated by Transforming Growth Factor-β1 in Keratinocytes
  Laboratory Investigation, 2003
• Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas
  Journal of Surgical Oncology, 2002
• New functions for the matrix metalloproteinases in cancer progression
  Nature Reviews Cancer, 2002
• Expression of Laminin-5-γ-2 Chain in Intraductal Papillary-Mucinous and Invasive Ductal Tumors of the Pancreas
  Laboratory Investigation, 2001